Literature DB >> 16779702

Cytotoxic properties of tyloxapol.

Jung-hua Steven Kuo1, Ming-shiou Jan, Hsuan Wen Chiu.   

Abstract

PURPOSE: Tyloxapol, a viscous polymer of the alkyl aryl polyether alcohol type, is classified as a nonionic surfactant and is widely used in biomedical applications. Although tyloxapol has been reported to be cytotoxic in various cell lines, there is no published information about its possible mechanisms of cell death. Hence, the objective of this study was to determine whether tyloxapol causes apoptosis or necrosis. These data could be helpful for a better understanding of the action of tyloxapol in cellular systems.
METHODS: RAW 264.7 (murine macrophage-like) cells and NIH/3T3 (mouse fibroblast) cells were treated with tyloxapol, and the activity of dehydrogenases in those cells, an indicator of cell viability, was assessed. The cell morphology changes induced by tyloxapol treatment were detected using propidium iodide nuclear staining. The hallmarks of apoptotic cells were characterized using DNA fragmentation assays, DNA fluorescence staining, and then flow analysis.
RESULTS: Tyloxapol treatment produced dose- and time-dependent cytotoxicity. Tyloxapol treatment damaged RAW 264.7 cells more than it damaged NIH/3T3 cells. All the cells exposed to tyloxapol showed some morphological features of apoptosis, such as chromatin condensation and cell shrinkage. Typical apoptotic ladders were observed in DNA extracted from tyloxapol-treated cells. Flow cytometric analysis revealed an increase in the hypodiploid DNA population (sub-G1), indicating that DNA cleavage occurred after tyloxapol treatment. In addition, we showed that pretreating cells with zVAD-fmk, a general caspase inhibitor, did not prevent tyloxapol-induced apoptosis. The cytotoxicity of tyloxapol can be reduced by adding a nontoxic lipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine to attenuate the interaction of tyloxapol with the cell membrane.
CONCLUSIONS: Our results indicate that tyloxapol induces apoptosis in RAW 264.7 and NIH/3T3 cells. These data provide a novel insight into the cytotoxic action of tyloxapol at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16779702     DOI: 10.1007/s11095-006-0281-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro.

Authors:  J F Kukowska-Latallo; C Chen; J Eichman; A U Bielinska; J R Baker
Journal:  Biochem Biophys Res Commun       Date:  1999-10-14       Impact factor: 3.575

Review 2.  Chromatin and cell death.

Authors:  Marco E Bianchi; Angelo Manfredi
Journal:  Biochim Biophys Acta       Date:  2004-03-15

3.  Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.

Authors:  M D Jacobsen; M Weil; M C Raff
Journal:  J Cell Biol       Date:  1996-06       Impact factor: 10.539

Review 4.  Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.

Authors:  K L Dechant; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 5.  To die or not to die: an overview of apoptosis and its role in disease.

Authors:  S W Hetts
Journal:  JAMA       Date:  1998-01-28       Impact factor: 56.272

6.  Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum.

Authors:  A J Ghio; B C Marshall; J L Diaz; T Hasegawa; W Samuelson; D Povia; T P Kennedy; C A Piantodosi
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

Review 7.  Features of apoptotic cells measured by flow cytometry.

Authors:  Z Darzynkiewicz; S Bruno; G Del Bino; W Gorczyca; M A Hotz; P Lassota; F Traganos
Journal:  Cytometry       Date:  1992

Review 8.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

9.  Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system.

Authors:  Neslihan Gursoy; Jean-Sebastien Garrigue; Alain Razafindratsita; Gregory Lambert; Simon Benita
Journal:  J Pharm Sci       Date:  2003-12       Impact factor: 3.534

10.  Tyloxapol attenuates the pathologic effects of endotoxin in rabbits and mortality following cecal ligation and puncture in rats by blockade of endotoxin receptor-ligand interactions.

Authors:  Vladimir B Serikov; T V Glazanova; E H Jerome; N W Fleming; Haruki Higashimori; N C Staub
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

View more
  2 in total

1.  Punctal Congestion Syndrome: A Reversible, Functional Punctal Stenosis Causing Epiphora in the Setting of Chronic Pretarsal Conjunctivitis.

Authors:  Yandong Bian; Stacy M Scofield-Kaplan; Christine Zemsky; Thalmon Campagnoli; Larissa Ghadiali; Lora R Dagi Glass; Brigitte Sallee; Donald V Belsito; Bryan J Winn
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 May-Jun 01       Impact factor: 1.746

Review 2.  Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies.

Authors:  Tatiana A Korolenko; Thomas P Johnston; Vaclav Vetvicka
Journal:  Molecules       Date:  2020-10-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.